Summary
The effects of the combined adrenergic alpha- and beta-receptor blocking compound labetalol on the systemic and pulmonary circulation were studied after its acute and long-term administration to patients with essential hypertension (WHO grade I–II). Nine men and one woman (mean age 46 years) participated in the acute study. Cardiac index, systemic blood pressure, pulmonary artery pressure and heart rate were measured at rest in the supine and upright positions, and during supine exercise at two work loads (50 and 100 watt), before and after intravenous administration of labetalol 50 mg. Eight of the men were re-examined after three months oral treatment with labetalol 600–900 mg daily. In the acute study cardiac index was unchanged by labetalol, except at the work load of 100 watt, when it decreased by 18.7%. The mean blood pressure decreased under all conditions; 11.6 mm Hg at supine rest, 22.3 mm Hg in the upright position, and by 15.9 mm Hg and 16.9 mm Hg at the two work loads. Heart rate was unchanged at supine rest, but was reduced in the upright position 9,0% and during exercise — at 50 watt by 9.3%, and at 100 watt by 10.3%. Systemic vascular resistance decreased at rest in the supine and upright positions, but not during exercise. The pulmonary artery pressure remained unchanged both at rest and during exercise. In the long-term study cardiac index was unchanged except at the heavy work load, when it decreased by 11.4%. Mean blood pressure was reduced significantly under all circumstances, by 14.6 mm Hg at supine rest, 16.8 mm Hg in the upright positions, and by 13.9 mm and 13.4 mm, respectively, at the two work loads. Heart rate was reduced both at rest 13.6% and during exercise at the two work loads 9.6% and 12.4%. Systemic vascular resistance decreased at rest, but not during exercise. The pulmonary artery pressure were unchanged. Thus, the haemodynamic patterns after acute and long-term administration of labetalol were essentially similar, which suggests that the agent is suitable both for acute and long-term treatment of hypertension, at least from a haemodynamic point of view.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lund-Johansen, P.: Haemodynamic alterations in essential hypertension. In: Hypertension: Mechanism and Management. Onestei, G.G., Kim, K.E., Mayer, I.H. (eds.), pp. 43–50. New York: Grune and Stratton 1973
Zacest, R., Gilmore, E., Koch-Weser, I.: Treatment of essential hypertension with combined vasodilation and β-adrenergic blockage. N. Engl. J. Med.286, 617–622 (1972)
Richards, D.A., Tuckman, I., Prichard, B.N.C.: Assessment of α and β-adrenoceptor blocking actions of labetalol. Br. J. Clin. Pharmacol.3, 849–855 (1976)
Farmer, J.B., Kennedy, I., Levy, G.P., Marshall, R.J.: Pharmacology of AH 5158; a drug which blocks both α- and β-adrenoceptors. Br. J. Pharmacol.45, 660–675 (1972)
Frick, M.H., Pörsti, P.: Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension. Br. Med. J.1976/I, 1046–1048
Dent, R., Kellaway, G.S.M.: A pilot trial of labetalol (AH 5158A) a combined alpha and beta blocker in the treatment of hypertension. N. Z. Med. J.86, 213–215 (1977)
Hansson, L., Hänel, B.: Antihypertensive effect of labetalol, a new alpha- and beta adrenergic blocking agent. Int. J. Clin. Pharmacol.14, 195–198 (1976)
Prichard, B.N.C., Boakes, A.I.: Labetalol in long-term treatment of hypertension. Br. J. Clin. Pharmacol. Suppl.3, 743–750 (1976)
Prichard, B.N.C., Thompson, F.O., Boakes, A.J., Joekes, A.M.: Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydralazine, and diazoxide: the use of AH 5158 in the treatment of hypertension. Clin. Sci. Mol. Med.48, 97s-100s (1975)
Rønne-Rasmussen, J.O., Andersen, G.S., Bowal Jensen, N., Anderson, E.: Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension. Br. J. Clin. Pharmacol. Suppl.3, 805–808 (1976)
Caesar, J., Shaldon, S., Chiandussi, L., Guevarar, L., Sherlock, Sheila: The use of indocyanine green in the measurements of hepatic blood flow and as a test of hepatic function. Clin. Sci21, 43–57 (1961)
Forrester, J.S., Ganz, W., Diamond, G., McHugh, T., Chonette, D.W., Swan, H.J.C.: Thermodilution cardiac output determination with af single flow-directed catheter. Am. Heart J.83, 306–311 (1972)
Ulrych, M., Frohlich, E.D., Dustan, H.P., Page, I.H.: Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation37, 411–416 (1968)
Tarazi, R.C., Dustan, H.P.: Beta-adrenergic blockade in hypertension: Practical and theoretical implications of long-term hemodynamic variations. Am. J. Cardiol.29, 633–640 (1972)
Majid, P. A., Meeran, M. K., Benaim, M. E., Sharma, B., Taylor, S. H.: Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension. Br. Heart J.36, 588–596 (1974)
Koch, G.: Acute hemodynamic effects of an alpha- and betareceptor blocking agent on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients. Am. Heart J.93, 585–591 (1977)
Metha, J., Cohn, J. N.: Hemodynamic effects of labetalol an alpha and beta adrenergic blocking agent in hypertensive subjects. Circulation55, 370–375 (1977)
Edwards, R. C., Raftery, E. B.: Haemodynamic effects of long-term oral labetalol. Br. J. Clin. Pharmacol. Suppl.3, 733–736 (1976)
Lund-Johansen, P., Bakke, O. M.: Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension. Br. J. Clin. Pharmacol.7, 169–174 (1979)
Widimsky, J., Berglund, E.: Effect of repeated exercise on the lesser circulation. J. Appl. Physiol.18, 983–986 (1963)
Price, H. L., Cooperman, L. H., Warden, J. C.: Control of the splanchnic circulation in man. Circ. Res.21, 333–340 (1967)
Trap-Jensen, J., Clausen, J. P., Noer, I., Larsen, O. A., Krogsgaard, A. R., Christensen, N. J.: The effects of beta-adrenoceptor blockers on cardiac output, liver blood flow and skeletal muscle blood flow in hypertensive patients Acta Physiol. Scand.30 (Suppl. 440), 27 (1976)
Clausen, J. P., Trap-Jensen, J., Svendsen, T. L., Hartling, O., Krogsgaard, A. R., Christensen, N. J.: Central and regional circulatory adjustments during emotional stress before and after combined alpha- and beta-receptor blockade. Coeur Med. Int.17 (Special) 135–141 (1978)
Moyer, J. H., Caplovitz, C.: The clinical results of oral and parenteral administration of 2-(N′p-Tolyl-N′-m-Hydroxy-phenylaminomethyl) Imidazoline Hydrochloride (Regitine) in the treatment of hypertension and an evaluation of the cerebral hemodynamic effects. Am. Heart J.45, 602–610 (1953)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Svendsen, T.L., Rasmussen, S., Hartling, O.J. et al. Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients. Eur J Clin Pharmacol 17, 5–11 (1980). https://doi.org/10.1007/BF00561670
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561670